160 related articles for article (PubMed ID: 32855707)
1. CCL26 regulates the proportion of CD4
Dong Z; Cao L; Guo L; Hong Y; Cao J; Chen X
Exp Ther Med; 2020 Oct; 20(4):3343-3351. PubMed ID: 32855707
[TBL] [Abstract][Full Text] [Related]
2. CCL11 increases the proportion of CD4+CD25+Foxp3+ Treg cells and the production of IL‑2 and TGF‑β by CD4+ T cells via the STAT5 signaling pathway.
Wang R; Huang K
Mol Med Rep; 2020 Jun; 21(6):2522-2532. PubMed ID: 32323817
[TBL] [Abstract][Full Text] [Related]
3. Promoted Generation of T Helper 1-Like Regulatory T Cells After Transient Middle Cerebral Artery Occlusion in Type-2 Diabetic Mice.
Jian L; Hu Y; Gao M; Shu L
Immunol Invest; 2023 Nov; 52(4):482-498. PubMed ID: 37076315
[TBL] [Abstract][Full Text] [Related]
4. The anti-CXCL4 antibody depletes CD4(+)CD25(+)FOXP3(+) regulatory T cells in CD4+ T cells from chronic osteomyelitis patients by the STAT5 pathway.
Huang K; Ge S
Ann Palliat Med; 2020 Sep; 9(5):2723-2730. PubMed ID: 32954739
[TBL] [Abstract][Full Text] [Related]
5. Preliminary investigation on the abnormal mechanism of CD4
Liu SX; Xiao HR; Wang GB; Chen XW; Li CG; Mai HR; Yuan XL; Liu GS; Wen FQ
Exp Ther Med; 2018 Aug; 16(2):1433-1441. PubMed ID: 30116392
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-targeted microbubble destruction-mediated Foxp3 knockdown may suppress the tumor growth of HCC mice by relieving immunosuppressive Tregs function.
Shi C; Zhang Y; Yang H; Dong T; Chen Y; Xu Y; Yang X; Liu P
Exp Ther Med; 2018 Jan; 15(1):31-38. PubMed ID: 29387180
[TBL] [Abstract][Full Text] [Related]
7. [Retracted] CCL26 regulates the proportion of CD4+CD25+FOXP3+ Tregs and the production of inflammatory factors in peripheral blood mononuclear cells following acute ischemic stroke via the STAT5 pathway.
Dong Z; Cao L; Guo L; Hong Y; Cao J; Chen X
Exp Ther Med; 2023 Apr; 25(4):174. PubMed ID: 37006875
[TBL] [Abstract][Full Text] [Related]
8. Effect of TGF-β1 on blood CD4
Hu Y; Qi W; Sun L; Zhou H; Zhou B; Yang Z
Exp Ther Med; 2018 Aug; 16(2):1403-1410. PubMed ID: 30112067
[TBL] [Abstract][Full Text] [Related]
9.
Zhou LY; Xie Y; Li Y
World J Gastroenterol; 2022 Jul; 28(26):3164-3176. PubMed ID: 36051332
[TBL] [Abstract][Full Text] [Related]
10. Gastric cancer cells induce human CD4+Foxp3+ regulatory T cells through the production of TGF-β1.
Yuan XL; Chen L; Zhang TT; Ma YH; Zhou YL; Zhao Y; Wang WW; Dong P; Yu L; Zhang YY; Shen LS
World J Gastroenterol; 2011 Apr; 17(15):2019-27. PubMed ID: 21528082
[TBL] [Abstract][Full Text] [Related]
11. [The decreased proportion of CD4
Yang D; Wu M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Sep; 38(9):831-836. PubMed ID: 36082714
[TBL] [Abstract][Full Text] [Related]
12. CXCL4 promoted the production of CD4
Xu T; Zhao J; Wang X; Meng Y; Zhao Z; Bao R; Deng X; Bian J; Yang T
Autoimmunity; 2020 Aug; 53(5):289-296. PubMed ID: 32538218
[No Abstract] [Full Text] [Related]
13. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
15. CD4
Qin S; Li L; Liu J; Zhang J; Xiao Q; Fan Y; Wei X
J Int Med Res; 2020 Dec; 48(12):300060520980940. PubMed ID: 33356705
[TBL] [Abstract][Full Text] [Related]
16. Human umbilical vein endothelial cells promote the inhibitory activation of CD4(+)CD25(+)Foxp3(+) regulatory T cells via PD-L1.
Chen WJ; Hu XF; Yan M; Zhang WY; Mao XB; Shu YW
Atherosclerosis; 2016 Jan; 244():108-12. PubMed ID: 26615520
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin combined with allogenic immature dendritic cells selectively expands CD4+CD25+Foxp3+ regulatory T cells in rats.
Wang GY; Zhang Q; Yang Y; Chen WJ; Liu W; Jiang N; Chen GH
Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):203-8. PubMed ID: 22484590
[TBL] [Abstract][Full Text] [Related]
18. STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells.
Passerini L; Allan SE; Battaglia M; Di Nunzio S; Alstad AN; Levings MK; Roncarolo MG; Bacchetta R
Int Immunol; 2008 Mar; 20(3):421-31. PubMed ID: 18270368
[TBL] [Abstract][Full Text] [Related]
19. T regulatory lymphocytes in type 1 diabetes: Impaired CD25 expression and IL-2 induced STAT5 phosphorylation in pediatric patients.
Parackova Z; Kayserova J; Danova K; Sismova K; Dudkova E; Sumnik Z; Kolouskova S; Lebl J; Stechova K; Sediva A
Autoimmunity; 2016 Dec; 49(8):523-531. PubMed ID: 27560779
[TBL] [Abstract][Full Text] [Related]
20. Strong impact of CD4+ Foxp3+ regulatory T cells and limited effect of T cell-derived IL-10 on pathogen clearance during Plasmodium yoelii infection.
Abel S; Lückheide N; Westendorf AM; Geffers R; Roers A; Müller W; Sparwasser T; Matuschewski K; Buer J; Hansen W
J Immunol; 2012 Jun; 188(11):5467-77. PubMed ID: 22544931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]